Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-208100
Filing Date
2020-08-03
Accepted
2020-08-03 16:31:41
Documents
2
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.JOE LEWISMVA INVESTORS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d935229dsc13g.htm SC 13G 90576
2 EX-99.1 d935229dex991.htm EX-99.1 6373
  Complete submission text file 0001193125-20-208100.txt   98608
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Subject) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91001 | Film No.: 201069592
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13G